In Vitro Antifungal Activity of Ankaferd Blood Stopper Against Candida albicans  Sevgi Ciftci, PhD, Fahriye Keskin, PhD, Sema Keceli Ozcan, MD, PhD, Mehmet Ali Erdem, DDS, PhD, Burak Cankaya, DDS, PhD, Recep Bingol, PhD, Cetin Kasapoglu, DDS, PhD  Current Therapeutic Research  Volume 72, Issue 3, Pages 120-126 (June 2011) DOI: 10.1016/j.curtheres.2011.04.003 Copyright © 2011 Elsevier HS Journals, Inc. Terms and Conditions

Figure 1 The effect of different volumes of Ankaferd Blood Stopper on Candida albicans colonies. Current Therapeutic Research 2011 72, 120-126DOI: (10.1016/j.curtheres.2011.04.003) Copyright © 2011 Elsevier HS Journals, Inc. Terms and Conditions

Figure 2 The numbers of Candida colonies counted on agar plates inoculated with 10–3 dilution of 0.5 McFarland solution of Candida albicans containing Ankaferd Blood Stopper (ABS) and its dilutions after 10-, 20- and 40-minute incubations. Current Therapeutic Research 2011 72, 120-126DOI: (10.1016/j.curtheres.2011.04.003) Copyright © 2011 Elsevier HS Journals, Inc. Terms and Conditions

Figure 3 Inhibitory effect of active substance concentrations. Current Therapeutic Research 2011 72, 120-126DOI: (10.1016/j.curtheres.2011.04.003) Copyright © 2011 Elsevier HS Journals, Inc. Terms and Conditions